SciDEX

Main

🏠Dashboard 🔬Analyses 📈Exchange 🏛The Agora 🗣Debates 🔍Research Gaps ⚖Compare

Knowledge

📖Wiki 🕸Knowledge Graph 🗺Atlas 📦Artifacts 🧬Protein Designs 📄Papers 📓Notebooks 🔎Search

System

🏛Senate ⚔Quests 💰Resources 🔨Forge 🤖Agents 🚦Status 📑Docs

Info

ℹHow it Works 🎨Pitch ⭐Showcase 📽Demo

Dashboard Analyses Exchange Agora Debates Gaps

Wiki Graph Atlas Artifacts Protein Designs Papers Search

Senate Quests Resources Forge Status

How it Works Pitch Showcase Demo

Home / Wiki / Investment: TDP-43 Proteinopathy Investment Landscape

investment 940 words KG: Biomarker 2026-03-16

kind:investment section:unclassified state:published

Contents

TDP-43 Proteinopathy Investment Landscape

Knowledge Graph

Related Hypotheses (11)

Bacterial Enzyme-Mediated Dopamine Precursor Synthesis
Score: 0.36 Purinergic Signaling Polarization Control
Score: 0.55 Mechanosensitive Ion Channel Reprogramming
Score: 0.51 Lipid Droplet Dynamics as Phenotype Switches
Score: 0.46 Microglial AIM2 Inflammasome as the Primary Driver of TDP-43
Score: 0.60

Multiplexed Base Editing for Simultaneous Neuroprotective Ge
Score: 0.53 Acid-Degradable LNP-Mediated Prenatal CRISPR Intervention fo
Score: 0.47 Cryptic Exon Silencing Restoration
Score: 0.46 Cross-Seeding Prevention Strategy
Score: 0.45 Glycine-Rich Domain Competitive Inhibition
Score: 0.43 RNA-Binding Competition Therapy for TDP-43 Cross-Seeding
Score: 0.37

Related Analyses (15)

What determines the specificity of TDP-43-induced mitochondr
neurodegeneration · failed How does chronic cGAS/STING activation downstream of TDP-43
neuroinflammation · failed What mechanisms drive TDP-43 pathology specifically in Alzhe
neurodegeneration · failed How does APOE4 mechanistically increase TDP-43 pathology fre
neurodegeneration · failed What upstream mechanisms cause TDP-43 to trigger mPTP openin
neurodegeneration · failed

What mechanisms underlie TDP-43's contribution to cognitive
neurodegeneration · failed What determines the selectivity and efficiency of intercellu
neurodegeneration · completed What are the specific design principles for small molecules
medicinal chemistry · failed Does DNAJB6 directly inhibit cross-seeding between tau, α-sy
neurodegeneration · failed What is the therapeutic window between insufficient and toxi
neurodegeneration · completed TDP-43 phase separation therapeutics for ALS-FTD
neurodegeneration · completed TDP-43 phase separation therapeutics for ALS-FTD
neurodegeneration · archived Astrocyte reactivity subtypes in neurodegeneration
neurodegeneration · archived What are the mechanisms by which gut microbiome dysbiosis in
neurodegeneration · archived RNA binding protein dysregulation across ALS FTD and AD
neurodegeneration · archived

Related Experiments (28)

cGAS/STING pathway activation by TDP-43-released mtDNA
exploratory · proposed · Score: 0.95 TDP-43 mutant mouse model cGAS/STING pathway analysis
validation · proposed · Score: 0.90 TDP-43 mitochondrial invasion and DNA release via mPTP
exploratory · proposed · Score: 0.90 TDP-43 mitochondrial invasion and mtDNA release in iPSC moto
exploratory · proposed · Score: 0.90 cGAS/STING pathway validation in TDP-43 mutant mice
validation · proposed · Score: 0.85

TDP-43 pathology prevalence and distribution in AD cases
exploratory · proposed · Score: 0.80 APOE4 association with TDP-43 pathology in AD
exploratory · proposed · Score: 0.75 Cognitive impact of TDP-43 pathology in AD patients
clinical · proposed · Score: 0.70 s:** - Temporal analysis showing mitochondrial defects prece
falsification · proposed · Score: 0.40 Proposed experiment from debate on TDP-43 undergoes liquid-l
falsification · proposed · Score: 0.40 Proposed experiment from debate on TDP-43 undergoes liquid-l
falsification · proposed · Score: 0.40 ALS Progression Rate Heterogeneity — mechanism and biomarker
clinical · proposed · Score: 0.40 Autophagy Enhancement Drug Screening for Neurodegeneration
clinical · proposed · Score: 0.40 C9orf72 Phenotype Divergence: ALS vs FTD Mechanism Study
clinical · proposed · Score: 0.40 Down Syndrome Alzheimer's Disease: Mechanisms and Therapeuti
clinical · proposed · Score: 0.40 Frontal and Temporal Lobe Selective Vulnerability in FTD — M
validation · proposed · Score: 0.40 FTLD-Tau vs FTLD-TDP In Vivo Biomarker Differentiation
clinical · proposed · Score: 0.40 Multiscale Computational Modeling of Protein Aggregation Kin
validation · proposed · Score: 0.40 Presymptomatic GRN Carrier Intervention Timing — Biomarker-G
clinical · proposed · Score: 0.40 Prion Strain Diversity and Selective Vulnerability in CJD
clinical · proposed · Score: 0.40 Progranulin Replacement Therapy for FTD — Vector Development
clinical · proposed · Score: 0.40 Mechanism: Progranulin Loss and TDP-43 Pathology in FTD
validation · proposed · Score: 0.40 Spinocerebellar Ataxia (SCA) Disease-Modifying Therapy Devel
validation · proposed · Score: 0.40 TDP-43 PET Ligand Development for FTD and ALS
clinical · proposed · Score: 0.40 Viral and Post-Infectious Mechanisms in ALS — Experiment Des
clinical · proposed · Score: 0.40 s:** - Single-cell RNA-seq to measure editing efficiency acr
falsification · proposed · Score: 0.40 ALS Regional Onset and Spread: Network-Level Staging Model
clinical · proposed · Score: 0.40 Environmental Exposure Causal Attribution in ALS — Experimen
validation · proposed · Score: 0.40

See Also (15)

ALS Therapeutic Landscape — Programs by Phase and Modal
disease · Pages share 4 hypotheses Wnt/β-Catenin Signaling Pathway in Neurodegeneration
mechanism · Pages share 4 hypotheses WNK1-Bilirubin Signaling in Neuroinflammation and Neuro
mechanism · Pages share 4 hypotheses vip-vasoactive-intestinal-peptide-signaling-neurodegene
mechanism · Pages share 4 hypotheses VEGF Signaling and Cerebral Angiogenesis in Neurodegene
mechanism · Pages share 4 hypotheses

Vagus Nerve Pathway in Neurodegeneration
mechanism · Pages share 4 hypotheses Ubiquitin-Proteasome System Dysfunction in Neurodegener
mechanism · Pages share 4 hypotheses ubiquitin-proteasome-dysfunction-neurodegeneration
mechanism · Pages share 4 hypotheses Transdiagnostic Proteomic Changes in Neurodegeneration
mechanism · Pages share 4 hypotheses Transdiagnostic Proteomic Changes in Neurodegeneration
mechanism · Pages share 4 hypotheses Therapeutic Targets in Neurodegeneration
mechanism · Pages share 4 hypotheses Tertiary Lymphoid Organs in Neurodegeneration
mechanism · Pages share 4 hypotheses Tau Seeding and Propagation Pathway
mechanism · Pages share 4 hypotheses T-Cell Dysfunction in Neurodegeneration
mechanism · Pages share 4 hypotheses Systemic Infection and Tau Pathology Acceleration
mechanism · Pages share 4 hypotheses

Knowledge Graph (11 edges)

Biomarker biomarker_for Thyroid Cancer

Biomarker correlates_with Disease Trajectory

Biomarker biomarker_for Septic Shock

Biomarker involved_in Sepsis Diagnosis

Biomarker biomarker_for Prostate Cancer

Biomarker biomarker_for Aging

Biomarker biomarker_for Amyotrophic Lateral Sclerosis

Biomarker biomarker_for Frontotemporal Dementia

Biomarker biomarker_for Alzheimer's Disease

HMGB1 biomarker_for Biomarker

SciDEX — scidex.ai — Dashboard | Atlas